Pulsion and Philips Healthcare enhance their strong partnership

Pulsion Medical Systems and Philips Healthcare are two strong brands. Pulsion, one of the leading specialists for intelligent medical diagnosis and therapy management systems, now announced the extension of the alliance with Philips. Among other things the agreement will contain the integration of further Pulsion-technologies into the Philips patient monitoring systems.

Photo: Pulsion and Philips Healthcare enhance their strong partnership
Pulsion Medical Systems AG, specialist in minimally invasive cardiovascular monitoring of critically ill patients, and Philips Healthcare, worldwide market leader in patient monitoring, have agreed to extend their successful strategic collaboration.
The agreement covers several areas including future integration of Pulsion technologies into Philips patient monitoring systems. In the past, Philips Healthcare was the first leading manufacturer of patient monitoring systems to integrate Pulsion’s flagship technology PICCO. PICCO-Technology was exclusivly licensed for the Health Care Solutions Group by Hewlett-Packard (today Philips) in 1998. Since July 2000 it is available in the Philips monitoring systems CMS und IntelliVue (since July 2002) with full functionality. More than 11,000 modules have been installed worldwide down to the present day.
Signing this agreement marks a further step in Pulsion’s strategy of speeding up the global market penetration of its product lines by integration into multi-parameter monitoring systems of the major med-tech manufactures.


Read all latest stories

Related articles


Article • Transformative technology

Generative AI in healthcare: More than a chatbot

‘Computer, why did the doctor take that MRI scan of my leg? And what did it show?’: Popularized by OpenAI’s ChatGPT, generative artificial intelligence (AI) is already beginning to see…


Article • Oncology imaging

The expanding role of CT in lung cancer management

While screening programs for several of the commonest cancers are now well established, lung cancer screening has yet to reach anywhere near the same proportion of at-risk patients.


Article • Philips presents portfolio update at ECR 2022

AI-powered MRI to increase imaging speed, reduce staff burden

The portfolio Philips presented at ECR 2022 revealed that the company not only advanced their products, but also listened to medical professionals and patients – and took their feedback to heart.

Related products

Subscribe to Newsletter